108 related articles for article (PubMed ID: 19366745)
21. [Which tocolytic drugs in case of preterm labor?].
Carbonne B; Tsatsaris V
J Gynecol Obstet Biol Reprod (Paris); 2002 Nov; 31(7 Suppl):5S96-104. PubMed ID: 12454631
[TBL] [Abstract][Full Text] [Related]
22. Atosiban and nifedipine in acute tocolysis: a comparative study.
Al-Omari WR; Al-Shammaa HB; Al-Tikriti EM; Ahmed KW
Eur J Obstet Gynecol Reprod Biol; 2006; 128(1-2):129-34. PubMed ID: 16446025
[TBL] [Abstract][Full Text] [Related]
23. Non-cardiogenic pulmonary edema in a woman treated with atosiban for preterm labor.
Hourbracq M; Mattuizzi A; Madar H; Sentilhes L
Eur J Obstet Gynecol Reprod Biol; 2017 Dec; 219():132-133. PubMed ID: 29102226
[No Abstract] [Full Text] [Related]
24. Emerging tocolytics for maintenance therapy of preterm labour: oxytocin antagonists and calcium channel blockers.
Kim A; Shim JY
BJOG; 2006 Dec; 113 Suppl 3():113-5. PubMed ID: 17206978
[TBL] [Abstract][Full Text] [Related]
25. [Tocolysis with nifedipine: its use in current practice. Gynecol Obstet Fertil 2005;33:483-7].
Carbonne B
Gynecol Obstet Fertil; 2006 Jan; 34(1):81-2. PubMed ID: 16406657
[No Abstract] [Full Text] [Related]
26. [Tocolysis by first intention with atosiban].
Gondry J
Gynecol Obstet Fertil; 2005 Apr; 33(4):260-2. PubMed ID: 15894214
[No Abstract] [Full Text] [Related]
27. Preterm labour. The present and future of tocolysis.
Giles W; Bisits A
Best Pract Res Clin Obstet Gynaecol; 2007 Oct; 21(5):857-68. PubMed ID: 17459777
[TBL] [Abstract][Full Text] [Related]
28. Effectiveness and safety of the oxytocin antagonist atosiban versus beta-adrenergic agonists in the treatment of preterm labour. The Worldwide Atosiban versus Beta-agonists Study Group.
Worldwide Atosiban versus Beta-agonists Study Group
BJOG; 2001 Feb; 108(2):133-42. PubMed ID: 11236112
[TBL] [Abstract][Full Text] [Related]
29. [Comparison of the cost of treatment of premature labor with atosiban or beta-sympathomimetics from the perspective of the health care payer--a pharmacoeconomic model].
Hrubý K
Ceska Gynekol; 2004 Mar; 69(2):96-105. PubMed ID: 15141520
[TBL] [Abstract][Full Text] [Related]
30. Pragmatic comparison of beta2-agonist side effects within the Worldwide Atosiban versus Beta Agonists study.
Chan J; Cabrol D; Ingemarsson I; Marsal K; Moutquin JM; Fisk NM
Eur J Obstet Gynecol Reprod Biol; 2006; 128(1-2):135-41. PubMed ID: 16504369
[TBL] [Abstract][Full Text] [Related]
31. Response to "The drugs we deserve".
Papatsonis DN; Flenady VJ; Dekker GA; Carbonne B; King JF
BJOG; 2004 Sep; 111(9):1025. PubMed ID: 15327624
[No Abstract] [Full Text] [Related]
32. Clinical practice evaluation of atosiban in preterm labour management in six European countries.
Husslein P; Roura LC; Dudenhausen J; Helmer H; Frydman R; Rizzo N; Schneider D;
BJOG; 2006 Dec; 113 Suppl 3():105-10. PubMed ID: 17206976
[TBL] [Abstract][Full Text] [Related]
33. [Clinical experience of using oxytocin antagonist atosiban in the rescue therapy of preterm labour].
Tan JP; Chen H; Du BJ; Liu YL; Wang YH; Zhang JP
Zhonghua Fu Chan Ke Za Zhi; 2008 Feb; 43(2):81-4. PubMed ID: 18683742
[TBL] [Abstract][Full Text] [Related]
34. Calcium channel blockers for the management of preterm birth: a review.
Nassar AH; Aoun J; Usta IM
Am J Perinatol; 2011 Jan; 28(1):57-66. PubMed ID: 20640972
[TBL] [Abstract][Full Text] [Related]
35. [Effectiveness and safety of atosiban vs. pulsatile administration of fenoterol in the treatment of preterm labour].
Nonnenmacher A; Hopp H; Dudenhausen J
Z Geburtshilfe Neonatol; 2009 Oct; 213(5):201-6. PubMed ID: 19856243
[TBL] [Abstract][Full Text] [Related]
36. Healthcare evaluation of the use of atosiban and fibronectin for the management of pre-term labour.
Siassakos D; O'Brien K; Draycott T
J Obstet Gynaecol; 2009 Aug; 29(6):507-11. PubMed ID: 19697198
[TBL] [Abstract][Full Text] [Related]
37. A cost decision analysis of 4 tocolytic drugs.
Hayes E; Moroz L; Pizzi L; Baxter J
Am J Obstet Gynecol; 2007 Oct; 197(4):383.e1-6. PubMed ID: 17904969
[TBL] [Abstract][Full Text] [Related]
38. 'Normal' pregnancy with adverse events on initial tocolytic treatment.
Dudenhausen J
BJOG; 2006 Dec; 113 Suppl 3():116-7. PubMed ID: 17206979
[TBL] [Abstract][Full Text] [Related]
39. Atosiban and non-cardiogenic pulmonary oedema.
Wright GA; Levy DM
Int J Obstet Anesth; 2012 Jan; 21(1):98; author reply 98-9. PubMed ID: 21840202
[No Abstract] [Full Text] [Related]
40. Calcium channel blockers for tocolysis: a review of their role and safety following reports of serious adverse events.
Oei SG
Eur J Obstet Gynecol Reprod Biol; 2006 Jun; 126(2):137-45. PubMed ID: 16567033
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
